Novartis AG (Novartis) is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products. It provides drugs for the treatment of cancer, cardiovascular diseases, dermatological conditions, neurological disorders, ophthalmic and respiratory diseases, immune disorders, and infections, among others. The company offers generic medicines and biosimilars through Sandoz. Novartis conducts research in various disease areas through the Novartis Institutes for BioMedical Research (NIBR). The company operates through a network of subsidiaries and offices across the Americas, Europe, the Middle East, Africa and Asia-Pacific. Novartis is headquartered in Basel, Switzerland.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Note: Some sections may be missing if data is unavailable for the company
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Novartis AG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Novartis AG Company Overview
Novartis AG Company Snapshot
Novartis AG Pipeline Products and Ongoing Clinical Trials Overview
Novartis AG - Pipeline Analysis Overview
Novartis AG - Major Products and Services
Novartis AG Pipeline Products by Development Stage
Novartis AG Ongoing Clinical Trials by Trial Status
Novartis AG Pipeline Products Overview
Novartis AG - Key Employees
Novartis AG - Key Employee Biographies
Novartis AG - Locations And Subsidiaries
Novartis AG Company Snapshot
Novartis AG Pipeline Products and Ongoing Clinical Trials Overview
Novartis AG - Pipeline Analysis Overview
- Business Description
Novartis AG - Major Products and Services
Novartis AG Pipeline Products by Development Stage
Novartis AG Ongoing Clinical Trials by Trial Status
Novartis AG Pipeline Products Overview
- 68Ga PSMA-R2
- 68Ga PSMA-R2 Product Overview
- 68Ga PSMA-R2 Clinical Trial
- 68Ga-NeoB
- 68Ga-NeoB Product Overview
- 68Ga-NeoB Clinical Trial
- 68GaFF-10158
- 68GaFF-10158 Product Overview
- 99mTc-Annexin-V-128
- 99mTc-Annexin-V-128 Product Overview
- Amblyopad
- Amblyopad Product Overview
- EC0652 - Prostate Cancer
- EC0652 - Prostate Cancer Product Overview
- Fibropad Patch
- Fibropad Patch Product Overview
- FOLCEPRI
- FOLCEPRI Product Overview
- FreePath Drug Delivery System
- FreePath Drug Delivery System Product Overview
- Prevent GI Sealant
- Prevent GI Sealant Product Overview
- Solis Multi-Dose Dry Powder Inhaler
- Solis Multi-Dose Dry Powder Inhaler Product Overview
- Unit-Dose Dry Powder Inhaler
- Unit-Dose Dry Powder Inhaler Product Overview
- VAL050 pMDI Valve / Actuator
- VAL050 pMDI Valve / Actuator Product Overview
Novartis AG - Key Employees
Novartis AG - Key Employee Biographies
Novartis AG - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
Recent Developments
Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Generex Biotechnology Corp
- AstraZeneca Plc
- Acceleron Pharma Inc
- Johnson & Johnson
- GlaxoSmithKline Plc
- Flarer SA
- AbbVie Inc
- Cassava Sciences Inc
- Yumanity Therapeutics Inc
- Antion Biosciences SA
- GW Pharmaceuticals Ltd
- Eli Lilly and Co
- Sanofi
- Verona Pharma Plc
- Novo Nordisk AS
- Kuros Biosciences AG
- Takeda Pharmaceutical Co Ltd
- Merck & Co Inc
- Curis Inc
- Bristol-Myers Squibb Co
- Addex Therapeutics Ltd
- Pfizer Inc
- F. Hoffmann-La Roche Ltd
- SELLAS Life Sciences Group Inc
